Document Type
Article
Publication Date
10-24-2023
Abstract
The U.S. government’s recent but unusual push to negotiate drug prices has struck a chord with many Americans, with polls showing a significant, bipartisan majority favoring the action.This action presents an opportunity to appreciate medical patents’ role in spurring innovation forward. Amid changing policies, medical patents shape the accessibility and affordability of care through their impact on drug pricing. Drug prices in the United States are notably high—about 2.4 times those in other developed countries.
This post was originally published on the Cardozo Arts & Entertainment Law Journal website on October 24, 2023. The original post can be accessed via the Archived Link button above.
Recommended Citation
Halwani, Eddie, "The Economics of Medical Patents And The U.S. Government’s Role In Drug Price Negotiations" (2023). AELJ Blog. 360.
https://larc.cardozo.yu.edu/aelj-blog/360
